POWER CELL INC
10QSB, 1999-04-28
BLANK CHECKS
Previous: MFS SERIES TRUST I, NSAR-A, 1999-04-28
Next: NABORS INDUSTRIES INC, DEF 14A, 1999-04-28



       




                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB


[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
       OF 1934

                 For the quarterly period ended March 31, 1999

                                       OR

[ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934

For the transition period from ______________ to _________________

Commission File Number 0-15379

                                POWER-CELL, INC.
              Exact name of Registrant as specified in its charter

         Colorado                                        84-1029701        
State of Incorporation                        IRS Employer Identification Number


                               10711 Preston Road
                                    Suite 250
                               Dallas, Texas 75230
                                  214/692-9921
           Address and telephone number of principal executive offices

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  Registrant  was
required to file such reports),  and (2) has been subject to filing requirements
for the past 90 days.

                                    Yes X No


The number of shares of common stock of the Registrant  outstanding at March 31,
1999 was 6,419,540.



<PAGE>


<TABLE>

<CAPTION>

                                POWER-CELL, INC.
                        (a development stage enterprise)

                                POWER-CELL, INC.


             INDEX

Part I       Financial Information                                                   PAGE
             ---------------------                                                   ----
<S>                                                                                   <C>


             Balance sheet - March 31, 1999 (unaudited)                               3

             Unaudited condensed statements of operations - three and nine month
             periods ended March 31, 1999 and 1998 and the period from
             January 21, 1987 (date of incorporation) to March 31, 1999               4

             Unaudited  condensed  statements of cash flows - nine months ended
             March 31, 1999 and 1998 and the period from
             January 21, 1987 (date of incorporation) to March 31, 1999               5

             Note to condensed financial statements                                   6

             Management's discussion and analysis of financial condition and
             results of operations                                                    7

Part II      Signature Page                                                           8


</TABLE>








                                        2

<PAGE>

<TABLE>

<CAPTION>


                                POWER-CELL, INC.
                        (a development stage enterprise)

                                  BALANCE SHEET
                                   (Unaudited)

                                                                               March 31, 1999
                                                                               --------------
<S>                                                                             <C>

                                      ASSET



ASSETS                                                                           $      --   
                                                                                 ===========

                      LIABILITIES AND STOCKHOLDERS' DEFICIT



CURRENT LIABILITIES - Accounts payable and accrued expenses                      $    32,198

STOCKHOLDERS' DEFICIT:
     Common stock, par value $.0001 per share, 750,000,000 shares
       authorized; 6,419,540 shares issued and outstanding                               642
     Additional paid-in capital                                                    1,571,340
     Deficit accumulated in the development stage                                 (1,604,180)
                                                                                 -----------

           Total Stockholders' Deficit                                               (32,198)

           Total Liabilities and Stockholders' Deficit                           $      --
                                                                                 ===========

</TABLE>










                 See accompanying note to financial statements.
             
                                        3

<PAGE>


<TABLE>

<CAPTION>

                                            
                                POWER-CELL, INC.
                        (a development stage enterprise)

                            STATEMENTS OF OPERATIONS
                                   (Unaudited)


                                       Three Months                  Nine Months          
                                           Ended                       Ended             For the Period From           
                                         March 31,                    March 31,         January 21, 1987 (Date 
                                        -----------                  -----------         of Incorporation) to   
                                   1999             1998          1999          1998       March 31, 1999
                                  ------           ------        ------        ------      ---------------
<S>                              <C>            <C>            <C>            <C>            <C>    

REVENUE -
    Interest and other income    $      --      $      --      $      --      $      --      $   176,724

EXPENSES:
    Product development                 --             --             --             --          225,478
    General and administrative           952          1,350          7,796         15,176      1,510,933
    Interest                            --             --             --             --           32,706
    Impairment of investment            --             --             --             --           11,787
                                 -----------    -----------    -----------    -----------    -----------
         Total expenses                  952          1,350          7,796         15,176      1,780,904
                                 -----------    -----------    -----------    -----------    -----------

NET LOSS                         $      (952)   $    (1,350)   $    (7,796)   $   (15,176)   $(1,604,180)
                                 ===========    ===========    ===========    ===========    ===========



</TABLE>








                 See accompanying note to financial statements.

                                        4


<PAGE>

<TABLE>

<CAPTION>
                 
                                POWER-CELL, INC.
                        (a development stage enterprise)

                            STATEMENTS OF CASH FLOWS
                                   (Unaudited)


                                                                                 
                                                                                 For the Period from
                                                        Nine Months Ended         January 21, 1987
                                                              March 31,         (Date of Incorporation)   
                                                            -----------                  to
                                                      1999           1998           March 31,1999
                                                     ------         ------      ----------------------
<S>                                                <C>            <C>               <C>

OPERATING ACTIVITIES:
    Net loss                                       $    (7,796)   $   (15,176)      $(1,604,180)   
    Adjustments to reconcile net loss to                                                           
       net cash used in operating activities:                                                      
         Amortization and depreciation                    --             --              24,644    
         Issuance of stock options for services           --             --              24,094    
         Loss on theft of equipment                       --             --                 741    
         Impairment of investment in Partnership          --             --              11,787    
         Expenses paid by stockholder                    2,429         13,939            18,368    
    Changes in operating asset and liabilities:                                                    
         Other assets                                     --             --             (16,400)   
         Accounts payable and accrued expenses           4,250            587            32,198    
                                                   -----------    -----------       -----------    
NET CASH USED IN OPERATING                                                                         
   ACTIVITIES                                           (1,117)          (650)       (1,508,748)   
                                                   -----------    -----------       -----------    
                                                                                                   
INVESTING ACTIVITIES:                                                                              
    Purchase of office equipment                          --             --              (8,985)   
    Investment in limited partnership                     --             --             (31,787)   
                                                   -----------    -----------       -----------    
NET CASH USED IN INVESTING                                                                         
   ACTIVITIES                                             --             --             (40,772)   
                                                   -----------    -----------       -----------    
                                                                                                   
FINANCING ACTIVITIES:                                                                              
    Advance received                                      --             --              20,000    
    Issuance of common stock and exercise of                                                       
       warrants                                           --             --           1,533,020    
    Stock issuance costs                                  --             --              (3,500)   
                                                   -----------    -----------       -----------    
NET CASH PROVIDED BY FINANCING                                                                     
    ACTIVITIES                                            --             --           1,549,520    
                                                   -----------    -----------       -----------    
                                                                                                   
INCREASE (DECREASE) IN CASH AND                                                                    
   CASH EQUIVALENTS                                     (1,117)          (650)             --      
CASH AND CASH EQUIVALENTS AT                                                                       
   BEGINNING OF PERIOD                                   1,117            942              --      
                                                   -----------    -----------       -----------    
                                                                                                   
CASH AND CASH EQUIVALENTS AT END                                                                   
   OF PERIOD                                       $      --      $       292       $      --      
                                                   ===========    ===========       ===========    
                                                                                                   
</TABLE>
                                                                             

      
                 See accompanying note to financial statements.

                                        5


<PAGE>



                                             
                                POWER-CELL, INC.
                        (a development stage enterprise)

                          NOTE TO FINANCIAL STATEMENTS
                                   (Unaudited)

A.    Basis of Presentation
      ---------------------

      Certain  information  and  footnote   disclosures   normally  included  in
      financial  statements  prepared  in  accordance  with  generally  accepted
      accounting  principles  have been  condensed and omitted  pursuant to such
      rules and regulations,  although  management  believes the disclosures are
      adequate to make the information  presented not misleading.  These interim
      financial  statements  should be read in  conjunction  with the  Company's
      annual report and most recent financial  statements included in its report
      on Form 10-KSB for the year ended June 30, 1998 filed with the  Securities
      Exchange Commission.

      The interim financial  information included herein is unaudited;  however,
      such information reflects all the adjustments (consisting solely of normal
      recurring adjustments) which are, in the opinion of management,  necessary
      for a fair  statement  of  results  of  operations  and cash flows for the
      interim periods. The results of operations for the nine months ended March
      31, 1999 are not necessarily  indicative of the results to be expected for
      the full year.

                














                                        6

<PAGE>

                                            
                                POWER-CELL, INC.
                        (a development stage enterprise)

                          NOTE TO FINANCIAL STATEMENTS
                                   (Unaudited)

Management's  Discussion  and  Analysis of  Financial  Condition  and Results of
Operations Liquidity and Capital Resources

On October 21, 1992, the Company  entered into a limited  partnership  agreement
with several  other limited  partners and a sole general  partner to provide for
management,  funding,  manufacturing  and  marketing  of the Power Cell  reserve
battery unit on a worldwide basis.  The Company  initially owned an 11% interest
in the limited partnership, which may increase or decrease due to the occurrence
of certain events. The interest decreased to 7.35% during fiscal 1996 due to the
addition of outside investors,  resulting in a pro rata dilution. In addition, a
separate  license  royalty   agreement  between  the  Company  and  the  limited
partnership provides that the Company will receive royalty payments on all Power
Cell units produced and sold in the United States and its  territories.  Royalty
payments on  international  sales of Power Cell units will be paid to individual
international  rights holders, or their designees,  some of which are affiliates
of the Company,  and all of which are limited  partners in the  partnership,  as
follows:  one-third  (33  1/3%) to J. C.  Rambin;  one-third  (33  1/3%) to Rudy
Marich;  one-third  to Howard  Farkas (75% of 1/3) and Burt Kanter (25% of 1/3).
These royalty  payments will be due and payable when,  and if, royalty funds are
received.

The contract  agreement has no provision for direct funding of Power-Cell,  Inc.
Its  earnings,  if  any,  will  be  derived  from  an  interest  in the  limited
partnership together with royalties, if any, from the license royalty agreement.

On July 1, 1996,  Reserve Battery Cell, L.P. (Reserve Battery) announced initial
market  release  in select  cities  of the  Power  Cell  Reserve  Battery  unit.
Subsequently,  the  Company  was  informed  by Reserve  Battery,  Inc.  that all
marketing and operations  activities have ceased as a result of its inability to
source sufficient capital to sustain operations.

In April, 1999, Power-Cell,  Inc. and Park Pharmacy,  Inc. jointly announced the
signing of a definitive  agreement for Power-Cell,  Inc. to acquire 100% of Park
Pharmacy, Inc. in exchange for 80% of the then outstanding shares of Power-Cell,
Inc. in a tax free  exchange.  The parties will submit the  agreement as soon as
possible to the stockholders of Power-Cell,  Inc. for approval. The stockholders
will also be asked to vote for a new board of directors  who will be  designated
by Park Pharmacy.

Park  Pharmacy,  Inc. is a Dallas,  Texas based  development  stage company that
plans to acquire  several  independent  retail  pharmacies and  associated  home
healthcare  facilities.  Park Pharmacy was  established  in June 1998 to acquire
independent  pharmacies that have a demonstrated  history of  profitability.  In
addition to  prescription  drugs and general  merchandise,  the pharmacies  will
provide  the more  profitable,  higher  technical  products  such as  compounded
prescriptions and specialty medications, such as infusion therapy.

Results of Operations
- ---------------------

The Company has been engaged in  organizational  and capital raising  activities
since  inception  through March 31, 1999. It has not incurred major  operational
expenditures.  The losses  incurred  since  inception  primarily  reflect legal,
accounting,  and administrative  expenses associated with the preparation of the
merger documents and registration  statement,  product development and arranging
for the manufacture of its battery charger product for test marketing  purposes.
The Company had a working capital deficit as of March 31, 1999 of $32,198.




  
                                        7
 
<PAGE>



                                    SIGNATURE


Pursuant to the  requirements of Section 13 or 15(d) of the Securities  Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                                 
                                POWER-CELL, INC.
                                ----------------
                                  (Registrant)


Date:  April 27, 1999                      /s/  James C. Rambin
                                                ------------------------------- 
                                                James C. Rambin, President
                                                and Principal Financial Officer


















<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     
</LEGEND>
<CIK>                         0000798539                  
<NAME>                        Power-Cell, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     US DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              JUN-30-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   MAR-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         0
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               0
<PP&E>                                         0
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                                 0
<CURRENT-LIABILITIES>                          32,198
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       1,571,982
<OTHER-SE>                                     0
<TOTAL-LIABILITY-AND-EQUITY>                   0
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  0
<OTHER-EXPENSES>                               7,796
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (7,796)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (7,796)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (7,796)
<EPS-PRIMARY>                                  0
<EPS-DILUTED>                                  0
        



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission